InvestorsHub Logo
Followers 33
Posts 2934
Boards Moderated 1
Alias Born 10/24/2015

Re: biosectinvestor post# 461352

Sunday, 04/24/2022 6:42:10 PM

Sunday, April 24, 2022 6:42:10 PM

Post# of 732801

I believe that because it was a safety trial, they only injected one tumor, but also saw systemic immune response, though the details I do not have and that is to the best of my recollection.



Others, such as REPL have injected just a single lesion, but the systemic immune response was able to impact distal and non-injected lesions, with a number of responses (from memory, the ORR was over 33% with RP2).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News